Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients

Tae Jun Kim, Ja Seol Koo, Sung Jin Kim, Sung Noh Hong, You Sun Kim, Suk Kyun Yang, Young Ho Kim

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)


    Background and aim: Altered gene expression in intestinal mucosa is thought to contribute to inflammatory process in Crohn’s disease (CD). The present study investigated changes in the expression of genes associated with gut inflammation in CD patients by RNA microarray to identify disease biomarkers. Methods: Microarray analysis was carried out in formalin-fixed, paraffin-embedded intestinal tissue specimens from six CD patients who underwent surgery without prior treatment and from two healthy control subjects. Transcripts overexpressed in CD patients were validated by enzyme-linked immunosorbent assay (ELISA) using specimens from 46 CD patients and 60 healthy controls. Results: Among the genes over-expressed with statistical significance, five genes including decay-accelerating factor, interleukin-1 receptor (IL1R) A, tumour necrosis factor receptor 2, (C-X-C motif) ligand (CXCL) 1, and granzyme (GZM) B proposed to have functional association with CD were selected to validate the expressed transcripts in serum. Serum concentration of IL1RA, CXCL1, and GZMB measured by ELISA were significantly higher in CD patients. Conclusions: We identified that IL1RA, CXCL1, and GZMB are overexpressed in CD patients. Serum IL1RA and GZMB levels were markedly increased in CD patients, suggesting that these markers can serve as biomarkers to identify gut inflammation. Further studies will be required to evaluate this possibility.

    Original languageEnglish
    Pages (from-to)161-166
    Number of pages6
    Issue number2
    Publication statusPublished - 2018 Feb 17

    Bibliographical note

    Funding Information:
    This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI12C0130).

    Publisher Copyright:
    © 2017 Informa UK Limited, trading as Taylor & Francis Group.


    • Crohn’s disease
    • RNA microarray
    • biomarker
    • inflammatory bowel disease
    • transcripts

    ASJC Scopus subject areas

    • Biochemistry
    • Clinical Biochemistry
    • Health, Toxicology and Mutagenesis


    Dive into the research topics of 'Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients'. Together they form a unique fingerprint.

    Cite this